Research programme: HIV gp41 inhibitors - Whitehead Institute for Biomedical Research/Howard Hughes
Alternative Names: D-peptide inhibitors; HIV gp42 inhibitors - Whitehead Institute/Hughes Medical Institute/Massachusetts Insitute of Technol; IQN17Latest Information Update: 30 Apr 2002
At a glance
- Originator Nonindustrial sources
- Class
- Mechanism of Action HIV envelope protein gp41 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections